David A. Isenberg
AuthID: R-006-E33
31
TITLE: Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus
AUTHORS: Rita Quelhas da Costa; Elena Aguirre Alastuey, ME; David A Isenberg; Amanda M Saracino;
PUBLISHED: 2018, SOURCE: JAMA DERMATOLOGY, VOLUME: 154, ISSUE: 12
AUTHORS: Rita Quelhas da Costa; Elena Aguirre Alastuey, ME; David A Isenberg; Amanda M Saracino;
PUBLISHED: 2018, SOURCE: JAMA DERMATOLOGY, VOLUME: 154, ISSUE: 12
INDEXED IN: 
Scopus 
WOS
Scopus WOS32
TITLE: A study of the influence of ethnicity on serology and clinical features in lupus Full Text
AUTHORS: Morais, SA; Isenberg, DA;
PUBLISHED: 2017, SOURCE: LUPUS, VOLUME: 26, ISSUE: 1
AUTHORS: Morais, SA; Isenberg, DA;
PUBLISHED: 2017, SOURCE: LUPUS, VOLUME: 26, ISSUE: 1
INDEXED IN: WOS
WOS33
TITLE: Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness
AUTHORS: Sara Guerreiro Castro; David A Isenberg;
PUBLISHED: 2017, SOURCE: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, VOLUME: 9, ISSUE: 3
AUTHORS: Sara Guerreiro Castro; David A Isenberg;
PUBLISHED: 2017, SOURCE: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, VOLUME: 9, ISSUE: 3
INDEXED IN: Scopus WOS
Scopus WOS34
TITLE: Comment on: Musculoskeletal complication of haematological disease: Reply
AUTHORS: David A Isenberg; Sandra A Morais;
PUBLISHED: 2017, SOURCE: RHEUMATOLOGY, VOLUME: 56, ISSUE: 2
AUTHORS: David A Isenberg; Sandra A Morais;
PUBLISHED: 2017, SOURCE: RHEUMATOLOGY, VOLUME: 56, ISSUE: 2
INDEXED IN: WOS
WOS35
TITLE: Mixed connective tissue disease-enigma variations?
AUTHORS: Natalia C O Ciang; Nidia Pereira; David A Isenberg;
PUBLISHED: 2017, SOURCE: RHEUMATOLOGY, VOLUME: 56, ISSUE: 3
AUTHORS: Natalia C O Ciang; Nidia Pereira; David A Isenberg;
PUBLISHED: 2017, SOURCE: RHEUMATOLOGY, VOLUME: 56, ISSUE: 3
INDEXED IN: WOS
WOS36
TITLE: Current pharmacological treatment of idiopathic inflammatory myopathies
AUTHORS: Serena Fasano; Sara Custodio Alves; David A Isenberg;
PUBLISHED: 2016, SOURCE: EXPERT REVIEW OF CLINICAL PHARMACOLOGY, VOLUME: 9, ISSUE: 4
AUTHORS: Serena Fasano; Sara Custodio Alves; David A Isenberg;
PUBLISHED: 2016, SOURCE: EXPERT REVIEW OF CLINICAL PHARMACOLOGY, VOLUME: 9, ISSUE: 4
INDEXED IN: WOS 
CrossRef
WOS CrossRef37
TITLE: Musculoskeletal complications of haematological disease
AUTHORS: Sandra A Morais; Hannah E du Preez; Mohammed Rashid Akhtar; Susan Cross; David A Isenberg;
PUBLISHED: 2016, SOURCE: RHEUMATOLOGY, VOLUME: 55, ISSUE: 6
AUTHORS: Sandra A Morais; Hannah E du Preez; Mohammed Rashid Akhtar; Susan Cross; David A Isenberg;
PUBLISHED: 2016, SOURCE: RHEUMATOLOGY, VOLUME: 55, ISSUE: 6
38
TITLE: Biologic therapies in patients with neuropsychiatric systemic lupus erythematosus Full Text
AUTHORS: Farinha, F; Abrol, E; Isenberg, DA;
PUBLISHED: 2016, SOURCE: LUPUS, VOLUME: 25, ISSUE: 11
AUTHORS: Farinha, F; Abrol, E; Isenberg, DA;
PUBLISHED: 2016, SOURCE: LUPUS, VOLUME: 25, ISSUE: 11
39
TITLE: Why do patients with myositis die? A retrospective analysis of a single-centre cohort
AUTHORS: Amaral A Silva; Cogollo, E; Isenberg, DA;
PUBLISHED: 2016, SOURCE: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, VOLUME: 34, ISSUE: 5
AUTHORS: Amaral A Silva; Cogollo, E; Isenberg, DA;
PUBLISHED: 2016, SOURCE: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, VOLUME: 34, ISSUE: 5
INDEXED IN: WOS
WOS40
TITLE: Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review Full Text
AUTHORS: Custodio C Alves; Fasano, S; Isenberg, DA;
PUBLISHED: 2016, SOURCE: LUPUS, VOLUME: 25, ISSUE: 14
AUTHORS: Custodio C Alves; Fasano, S; Isenberg, DA;
PUBLISHED: 2016, SOURCE: LUPUS, VOLUME: 25, ISSUE: 14
INDEXED IN: Scopus WOS
Scopus WOS